How to Localize Labels and Instructions for Overseas Registration of Dental Devices?

Key Summary

Localization of labels and instructions for dental device overseas registration is a systematic regulatory conversion, not mere translation. This article explains the key steps: determining device classification and risk class, assessing reusable technical documentation, meeting target market requirements for language,

Key Takeaways

Localizing labels and instructions for overseas registration of dental devices is not simply a matter of translating text; it is a systematic conversion to meet the regulatory requirements of the target market. Manufacturers must first determine whether the product falls within the scope of dental device regulation in the target country, then establish the risk class based on intended use, invasiveness, and anatomical site, and subsequently select the appropriate registration pathway. The core of localization is confirming the target country's specific requirements for labels, instructions, language, symbols, warnings, manufacturer information, and Unique Device Identification (UDI).

Typically, NMPA registration dossiers, CE technical files, FDA 510(k) submissions, or ISO 13485 quality system documentation can serve as a foundation, but clinical evaluation, performance verification, and risk management reports must be reassessed to ensure they meet local requirements. Label and instruction localization involves content rewriting, format adjustment, regulatory symbol localization, translation certification, and local agent responsibilities. Manufacturers often overlook the local agent's control over label changes, ongoing compliance obligations during the certificate's validity period, and the balance between shared technical files and localization differences in multi-country registrations. It is recommended to clarify the target market list, classification results, language requirements, agent authorization scope, and post-market update mechanisms at the early stage of the project to avoid deficiencies, rejection, or post-market compliance risks.

Applicable Scenarios and Core Issues

During overseas registration of dental devices, label and instruction localization is an unavoidable component of the registration dossier. Whether entering GHWP member countries, Southeast Asia, the Middle East, or Latin America, regulatory authorities impose specific technical and language requirements on labels and instructions. Manufacturers often mistake localization for translation; in reality, it is a regulatory conversion process that requires rebuilding content by considering product classification, risk class, target market regulations, language conventions, and differences in medical practice.

Applicable scenarios include: first-time registration of a dental device in a target country, updating labels and instructions for an existing registration certificate, modifying labels and instructions due to regulatory changes or product changes, and conducting a unified regulatory assessment for simultaneous multi-country registration. The core issue is determining which existing documents can be reused and which must be redone, while not overlooking target market requirements for local agents, post-market surveillance, and change control.

Registration Decision Logic

Before starting localization work, manufacturers need to complete a decision-making process based on clear logic, rather than directly engaging a translation company. The first step is to determine whether the product falls within the scope of medical device regulation in the target country. Many dental devices, such as dental burs, impression materials, dental implants, and tooth whitening products, may have different regulatory classifications in different countries. The second step is to determine the risk class, usually categorized as low, medium, or high based on contact duration, invasiveness, and absorbability, which determines whether the registration pathway is notification, listing, or approval.

The third step is to assess whether existing NMPA, CE, FDA, ISO 13485, MDSAP, or other market documentation can be reused. The core criterion is whether the technical files contain data that meets the target country's requirements, not whether the certificate names are identical. The fourth step is to confirm the target country's specific requirements for labels and instructions, including language, content structure, symbols, warnings, contraindications, caution statements, manufacturer and agent information, and UDI. For GHWP member countries and multi-country registration scenarios, priority should be given to evaluating the possibility of sharing core technical files and the differences that must be localized for each market.

Documentation and Evidence

Documents required for label and instruction localization include: original product labels and instructions, target market language versions, product classification basis documents, risk management files, performance verification results, clinical evaluations or clinical evidence, quality system certificates, certificates of origin from the manufacturing country, and local agent authorization agreements. These documents are not simply accumulated but must form a chain of evidence.

Manufacturers must provide clear product description, intended use, instructions for use, contraindications, and precautions. For dental devices, special attention must be paid to the accuracy of information regarding material composition, biocompatibility, sterilization methods, electrical safety, radiation safety, and MRI compatibility. If the product is registered in multiple countries, a difference analysis matrix should be prepared, indicating which content is identical and which has been modified due to regulatory differences.

Local evidence required for localization includes: proof of translation accuracy in the target language, qualification of the translation company or sworn translation certificate, and confirmation letters from the local agent regarding label and instruction content. For some markets, label mock-ups, instruction layout files, and warning symbols required by the target country may also be needed.

Common Mistakes

Treating translation as localization and failing to conduct a regulatory gap analysis, resulting in label content missing information that is mandatory in the target country.
Ignoring differences in the definition and classification of medical devices among countries; for example, a dental material may be a medical device in Country A but a cosmetic or pharmaceutical in Country B.
Directly using the English content from CE or FDA labels without converting to the local language or adjusting units of measurement, symbols, and warnings.
Not designating a local agent or authorized representative, causing the contact information on the label to be non-compliant and the registration to be rejected.
Overlooking UDI requirements or using incompatible coding systems, leading to identification and traceability problems.
After registration approval, failing to establish a change control procedure for labels and instructions, resulting in non-compliant post-market modifications.
In multi-country registration, translating labels and instructions independently for each country, wasting resources an d making unified maintenance difficult.

Manufacturer Preparation Checklist

Define the target market list and confirm the device classification and registration pathway for each country.
Conduct a regulatory gap analysis, checking item by item whether existing technical files meet the target country's requirements.
Establish a master label and instruction document to manage the source language version and multiple language versions in a unified manner.
Determine the local agent or authorized representative and clarify their responsibilities for label review and change reporting.
Develop a translation and review process to ensure accurate translation of medical terminology, warnings, and symbols.
Complete the design of the target language instruction format, including fonts, images, charts, and layout requirements.
Prepare a UDI allocation plan and device identification information to ensure compliance with the target country's UDI rules.
Set up a post-registration label and instruction update mechanism to track regulatory changes and certificate renewal requirements.

AIMEILI's Viewpoint

As a consultancy providing long-term international registration services, we have observed that the most typical problem is that manufacturers, when entering a new market, often prioritize product testing and quality system certification, and only consider labels and instructions at the end. This results in overall deficiencies because labels do not meet local regulations, wasting time and increasing costs. In fact, manufacturers should treat label and instruction localization as part of their registration strategy, clarifying the target market's language requirements, agent responsibilities, and change control at the outset of the project.

The first priority in the early stage is not translation, but confirming the product's regulatory identity in the target country. The risk classification of dental devices directly determines the stringency of label and instruction review. In our view, the documents that can be reused are mainly product technical performance data, biocompatibility data, and ISO 13485 quality system documents, as they are generally internationally recognized. What must be localized are clinical evaluation, risk management, and label and instruction content, because different countries have varying requirements for clinical evidence, judgments of risk acceptability, and wording of warnings and contraindications.

Local agent and certificate control are extremely important. Many manufacturers register the certificate under the name of the local agent but overlook the mechanisms for agent replacement, termination of authorization, and certificate transfer. Once the agent relationship encounters problems, the agent information on the label must be promptly updated, or the legal marketing of the product will be affected. Furthermore, for multi-country registration, it is advisable to establish a unified core label master document while configuring country-specific localization pages. This ensures information consistency and allows efficient adjustments when country regulations change, reducing the risk of redundant rework and deficiencies.

Frequently Asked Questions

What information in the localization of dental device labels and instructions is most often overlooked?

The most common omissions are updates to the manufacturer's address and local agent information, as well as warnings adapted to local language conventions. Additionally, some countries require labels to include specific symbols, such as “caution” or “read instructions before use,” and these symbols must strictly follow local standards; they cannot be directly copied from symbols used in CE marking.

If a product has obtained CE certification, can its CE labels and instructions be directly used in a new market?

No. CE certification primarily demonstrates compliance with EU regulations, but the target market may have different regulatory requirements. Even if technical files can be reused, clinical evaluation, risk management, and label formats need to be rechecked. For example, some countries in the Middle East and Southeast Asia require additional safety warnings and local language versions; without such differential adjustments, deficiencies are likely to be raised.

In multi-country registration, is it possible to prepare only one localized label and instruction?

It is not recommended to prepare only one version. Different countries have different requirements for language, units of measurement, symbols, and regulatory information. Even for the same product, the instruction versions for the Middle East and Southeast Asia need to be managed differently. We recommend adopting a master document plus localized pages approach to improve efficiency while ensuring compliance.

Continue Reading

Previous article: None

Next article: How to Choose a Local Agent for Overseas Registration of Laboratory Equipment?

Content Review and Applicability Boundary

Author: AIMEILI Regulatory Editorial Department

Professional review: AIMEILI Medical Device International Registration Project Team

Source principle: Priority is given to official regulatory agencies, international organizations, standards organizations, and publicly available regulatory materials; industry media and project experience are used only as supplementary judgment.

Applicability boundary: This article is for preliminary understanding, document preparation, and project planning only, and does not substitute for the formal requirements of the target country's regulatory authority, test conclusions, or legal advice.

Source and Language Notice

View Chinese original page

Need a registration pathway assessment?

Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.

Contact AIMEILI